Problem

Assort Health addresses the patient-access bottleneck in specialty healthcare: overloaded front desks and call centers, long hold times, missed calls, after-hours gaps, and fragmented administrative workflows. The company frames the underlying opportunity as part of healthcare’s $1.1 trillion annual administrative burden, where an unanswered call can mean a lost appointment, lost revenue, or even a lost patient. The main use case is high-volume, complex specialty scheduling, including referral-driven appointments that require real-time knowledge of provider availability, insurance, protocols, and scheduling rules.

The pain is measurable at the practice level. Michigan Orthopedic Surgeons managed more than 35,000 appointment calls per month, with patients waiting 15–40 minutes, a 35% call-drop rate, and millions of missed appointment opportunities annually. SENTA faced roughly 15,000 calls per month, average waits of 6 minutes and 36 seconds, staff overload, and the recurring cost of hiring and training additional call-center workers.

Product / Service

Assort sells an AI-powered patient-access and engagement platform built around specialty-specific voice agents. Its agents answer inbound calls, schedule, reschedule and cancel appointments, triage and route complex requests, conduct intake, process referrals and documents, manage eligibility and payments, handle refills and lab requests, and perform outbound follow-up. Rather than treating each call as an isolated transaction, the platform connects these workflows through shared patient context and practice-specific care protocols, using a dataset of more than 200 million patient interactions across 23 or more specialties.

The delivery model is an integrated software deployment rather than a standalone answering service: Assort keeps a practice’s existing phone and scheduling systems in place, connects to its EHR or practice-management system, and advertises live deployments in weeks. The benefit is always-on access without proportionally expanding front-office staff. Assort reports a 5% lift in appointment volume, a 115% increase in labor capacity, and a 4.3 out of 5 patient-satisfaction score; customer examples include a 97% reduction in hold time at SENTA and $2.3 million in additional appointment revenue at Michigan Orthopedic Surgeons.

Market

Assort competes in the healthcare AI voice-agent, patient-access, and administrative-workflow automation market. Its competitive set includes healthcare conversational and patient-access platforms such as Hyro, Luma Health, Artera, Notable Health, and Hello Patient; broader adjacent alternatives identified in market listings include NextGen Healthcare, AdvancedMD, Infinitus, Doctolib, Elation Health, and Klara. Assort’s positioning is differentiated by focusing on specialty-care complexity and extending beyond phone answering into a connected patient journey spanning scheduling, intake, referrals, follow-up, billing, and payments.

The company is commercially deployed rather than presented as a pre-revenue prototype. Founded in 2023 and launched in November 2023, Assort announced a $120 million Series C in June 2026 at a $1.2 billion valuation, bringing reported funding to $222 million. It says its platform is trusted by thousands of providers across 23 or more specialties and is powered by more than 190 million patient interactions, 62,000 care protocols, and 1.6 million decision pathways. The evidence establishes substantial deployment and customer traction, although it does not disclose Assort’s own revenue or ARR.